Status:

COMPLETED

Administration of Vaginal and Rectal Progesterone During FET Cycles

Lead Sponsor:

Thor Haahr

Conditions:

Infertility

Eligibility:

FEMALE

18-45 years

Brief Summary

Observational study of reproductive outcome after frozen embryo transfer in HRT with vaginal and rectal progesterone.

Detailed Description

Cohort of patients treated with autologous blastocyst at the Fertility clinic Skive Regional Hospital in HRT cycle. Estradiol stimulation started on second cycle day and on day 12 - 20 vaginal and rec...

Eligibility Criteria

Inclusion

  • Frozen embryo transfer cycles in HRT cycles

Exclusion

  • Donor frozen embryo transfer

Key Trial Info

Start Date :

February 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2019

Estimated Enrollment :

277 Patients enrolled

Trial Details

Trial ID

NCT03470610

Start Date

February 1 2018

End Date

September 1 2019

Last Update

September 10 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fertility Clinic Regional Hospital Skive

Skive, Denmark, 7800

Administration of Vaginal and Rectal Progesterone During FET Cycles | DecenTrialz